December 4-8, 2018, San Antonio, USA. Dr Razis participated in the 41st Annual San Antonio Breast Cancer Symposium (SABCS) as a co-author of a Hellenic Cooperative Oncology Group (HeCOG) poster on the “Prognostic impact of SRC, CDKN1B and JAK2 expression in metastatic breast cancer patients treated with trastuzumab”.
Leave a Reply